Non-discretionary programme to buy back shares
Lupus Capital plc will make a trading update on 29 February 2008.
Ahead of this, the Company announces that it has put in place an
irrevocable, non-discretionary programme allowing the Company to buy
back shares during the period beginning on 29 February 2008 and
ending on the day prior to publication of the Company's preliminary
results for the year ended 31 December 2007. The buy back programme
will be managed by JM Finn Capital Markets Ltd, an independent third
party, which makes its trading decisions in relation to the Company's
securities independently of, and uninfluenced by, the Company.
Share buy backs will be effected within pre-set parameters and will
be in accordance with the Company's general authority to repurchase
shares granted at the General Meeting held on 11 December 2007.
Consequently the maximum price paid will be limited to no more than
105 per cent of the average middle market quotations of the Company
shares for the 5 dealing days preceding the date of purchase.
---END OF MESSAGE---
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.